While several studies showed improved survival in patients with HER2-low breast cancer compared to patients with HER2-0 breast cancer [10,12,13,14,15,16], other studies showed no significant difference in survival between the two groups [9,17,18,19]. Here, ERBB2 is linked to breast carcinoma.